| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/23/2004 | CA2437998A1 Electrochemical test strip with an integrated microneedle and associated methods |
| 02/22/2004 | CA2437979A1 Molecular constructs and methods of use for detection of biochemical reactions |
| 02/19/2004 | WO2004015539A2 Managing and processing self-monitoring blood glucose |
| 02/19/2004 | WO2004015427A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19) |
| 02/19/2004 | WO2004015426A1 Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5) |
| 02/19/2004 | WO2004015425A1 Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha |
| 02/19/2004 | WO2004015424A1 Test piece for protein assay and process for producing the same |
| 02/19/2004 | WO2004015423A1 Method for protein determination, indicator for protein determination, and test piece for protein determination |
| 02/19/2004 | WO2004015422A2 Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1) |
| 02/19/2004 | WO2004015421A1 Method and device for identifying micro organisms |
| 02/19/2004 | WO2004015420A1 Method for diagnosing multiple sclerosis |
| 02/19/2004 | WO2004015419A1 Methods and systems for monitoring molecular interactions |
| 02/19/2004 | WO2004015418A1 Analysis system |
| 02/19/2004 | WO2004015417A1 A method and agents useful for same |
| 02/19/2004 | WO2004015416A2 Methods for the identification of agents with anti-microbial action |
| 02/19/2004 | WO2004015415A1 Method of screening drug |
| 02/19/2004 | WO2004015414A1 Device for analyzing properties of the global, in particular, primary hemostasis functions |
| 02/19/2004 | WO2004015413A1 The method and apparatus for determining the number of living cells in a test fluid |
| 02/19/2004 | WO2004015407A1 Ph measuring device with an axially movable penetrating electrode |
| 02/19/2004 | WO2004015398A1 Method and apparatus for determining fracture toughness |
| 02/19/2004 | WO2004015395A2 Method for identifying mhc-presented peptide epitopes for t cells |
| 02/19/2004 | WO2004015394A2 Cancer diagnostics and prognostics |
| 02/19/2004 | WO2004015393A2 Spotting pattern for placement of compounds in an array |
| 02/19/2004 | WO2004015392A2 Improved method to identify targeting molecules |
| 02/19/2004 | WO2004015391A2 Mass spectrometry-based identification of proteins |
| 02/19/2004 | WO2004015390A2 Lung cancer target proteins and use thereof |
| 02/19/2004 | WO2004015389A2 Methods of identifying compouds that modulate igg mediated mast cell activation |
| 02/19/2004 | WO2004015379A2 Apparatus and method for quantatively measuring liquid film drying rates on substrates |
| 02/19/2004 | WO2004015140A1 Methods for the treatment of dementia based on apo e genotype |
| 02/19/2004 | WO2004015138A1 Apparatus and methods for detecting dna in biological samples |
| 02/19/2004 | WO2004015135A1 Apolipoprotein e stable folding intermediate and methods of use thereof |
| 02/19/2004 | WO2004015133A2 Combinatorial synthesis system |
| 02/19/2004 | WO2004015131A2 Hepatitis c virus assays |
| 02/19/2004 | WO2004015130A2 Modulators of rabggt and methods of use thereof |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015090A2 Innervated artificial tissues and uses thereof |
| 02/19/2004 | WO2004015087A2 Eukaryotic genes involved in adult lifespan regulation |
| 02/19/2004 | WO2004015081A2 Methods for treating circadian rhythm phase disturbances |
| 02/19/2004 | WO2004015073A2 MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004015072A2 Mrbs as modifiers of the rb pathway and methods of use |
| 02/19/2004 | WO2004015071A2 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004015070A2 Isolation and identification of t cells |
| 02/19/2004 | WO2004015065A2 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
| 02/19/2004 | WO2004015064A2 Apparatus and method for analytical determinations |
| 02/19/2004 | WO2004015061A2 Determination of protein function |
| 02/19/2004 | WO2004014948A2 Gpi anchored glycoprotein aca as a novel tumor marker |
| 02/19/2004 | WO2004014941A1 Method for selective peptide labeling |
| 02/19/2004 | WO2004014936A2 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 02/19/2004 | WO2004014781A2 Liquid beverage conductivity detecting system |
| 02/19/2004 | WO2004014540A1 Color coated layer-by-layer microcapsules serving as combinatory analysis libraries and as specific optical sensors |
| 02/19/2004 | WO2004014434A1 A method for monitoring the effectiveness of tetracycline in the treatment of asthma |
| 02/19/2004 | WO2004014433A1 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 02/19/2004 | WO2004014359A1 Regulation of apob in treatment and drug screening for cardiovascular and metabolic disorders or syndromes |
| 02/19/2004 | WO2004014351A2 Use of cgrp antagonist compounds for treatment of psoriasis |
| 02/19/2004 | WO2004014319A2 Screening strategy for anticancer drugs |
| 02/19/2004 | WO2004014306A2 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 02/19/2004 | WO2004014301A2 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004014296A2 Method of detecting and preventing alzheimer’s disease, particularly at prodromal and early stages |
| 02/19/2004 | WO2004014222A2 Diagnosis and treatment of tuberous sclerosis |
| 02/19/2004 | WO2004014220A2 Devices and methods for detecting amniotic fluid in vaginal secretions |
| 02/19/2004 | WO2004007726A3 Brachyspira hyodysenteriae vaccine |
| 02/19/2004 | WO2003106964A3 High throughput methods and devices for assaying analytes in a fluid sample |
| 02/19/2004 | WO2003106697A3 Method and kit for identifying pseudomonas aeruginosa |
| 02/19/2004 | WO2003104812A3 DIAGNOSIS OF ALZHEIMER'S DISEASE BASED ON THE hAbeta42:hAbeta40 RATIO |
| 02/19/2004 | WO2003102584A3 Semaphorin-like proteins and methods of using same |
| 02/19/2004 | WO2003102541A3 Universal biosensor and methods of use |
| 02/19/2004 | WO2003100429A3 Diagnosis of hepatocellular carcinoma |
| 02/19/2004 | WO2003100376A3 Hematological assay and kit |
| 02/19/2004 | WO2003098185A3 Systems and methods for identifying organ transplant risk |
| 02/19/2004 | WO2003097852A3 Assay for identifying inhibitors of fc gamma riii signaling |
| 02/19/2004 | WO2003095620A3 Oocyte recording chamber |
| 02/19/2004 | WO2003095605A3 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors |
| 02/19/2004 | WO2003092581A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 02/19/2004 | WO2003091392A3 Polymer-coated substrates for immobilization of biomolecules and cells |
| 02/19/2004 | WO2003088979A3 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof |
| 02/19/2004 | WO2003085124A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2004 | WO2003084869A8 Method for separating single-wall carbon nanotubes and compositions thereof |
| 02/19/2004 | WO2003081203A3 Csf biomarker dilution factor corrections by mri imaging and algorithm |
| 02/19/2004 | WO2003080640B1 Lymphatic and blood endothelial cell genes |
| 02/19/2004 | WO2003080099A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10) |
| 02/19/2004 | WO2003078658A3 Methods for diagnosing and treating schizophrenia |
| 02/19/2004 | WO2003078584A3 Identifying peptide modifications |
| 02/19/2004 | WO2003078574A3 Novel metabolic targets and markers |
| 02/19/2004 | WO2003076892A3 Device and methods for measuring the response of at least one cell to a medium |
| 02/19/2004 | WO2003072803A3 Nanostructures containing antibody assembly units |
| 02/19/2004 | WO2003069347A3 Diagnostic and therapeutic use of caps |
| 02/19/2004 | WO2003065046A3 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| 02/19/2004 | WO2003065045A3 Diagnostics and therapeutics for diseases associated with the gpr65 receptor |
| 02/19/2004 | WO2003065043A3 Identification and relative quantification of proteins |
| 02/19/2004 | WO2003064460A3 Two gonadotropin releasing hormones and a method to isolate the same |
| 02/19/2004 | WO2003063777A3 Rapid phenotypic cell-based hiv assay |
| 02/19/2004 | WO2003060460B1 Multi-target screening |
| 02/19/2004 | WO2003059251A3 Antibody targeting compounds |
| 02/19/2004 | WO2003053136A3 Triple transgenic mouse model of alzheimer's disease |
| 02/19/2004 | WO2003049683A3 Use of parapox b2l protein to treat cancer and modify immune responses |
| 02/19/2004 | WO2003048780A3 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 02/19/2004 | WO2003048384A3 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms |
| 02/19/2004 | WO2003048193A3 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
| 02/19/2004 | WO2003046571A3 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease |
| 02/19/2004 | WO2003046564A3 Protein biopolymer markers predictive of alzheimers disease |